Atellica IM BR 27.29 Pre-treatment Reagent | REF 10995480

The Siemens Atellica IM BR 27.29 Pre-treatment Reagent (REF 10995480) is an in vitro diagnostic ancillary reagent designed for use with the Atellica IM Analyzer as part of the BR 27.29 (CA 27.29) breast cancer antigen immunoassay workflow. This pre-treatment reagent supports sample preparation steps required by the assay protocol on the Atellica Solution immunoassay platform.

Key Features
- Manufactured by Siemens Healthineers for the Atellica IM Analyzer
- Reference number (REF/UPN): 10995480
- Pre-treatment reagent component of the BR 27.29 immunoassay system
- Formulated for use within the Atellica Solution automated workflow
- Packaging configuration: Not specified in the located sources
- Storage and stability requirements: Not specified in the located sources
- Shelf life and on-board stability: Not specified in the located sources

Clinical Applications
- Intended as an ancillary reagent supporting the Atellica IM BR 27.29 assay, which measures the CA 27.29 breast cancer antigen
- Used in laboratory immunoassay testing workflows on the Atellica IM platform
- Indications, intended use population and clinical interpretation: Refer to the official Siemens Instructions for Use (IFU)

Product Information
- Brand: Siemens (Siemens Healthineers)
- Category: Siemens Atellica Reagents
- Product: Atellica IM BR 27.29 Pre-treatment Reagent
- REF / UPN: 10995480
- Compatible Platform: Atellica IM Analyzer / Atellica Solution
- Regulatory status, country availability and pricing: Not specified in the located sources. Buyers should confirm current availability, configuration and regulatory clearance with Siemens Healthineers or an authorized distributor prior to procurement.

REF / UPN10995480
Size

How It Works

1

Submit Your Request

Tell us what product you need and share a few details.

2

We Match You

We connect your request with the most relevant verified brands.

3

Receive Offers

Relevant supplier options can respond with availability, documentation context, and quote details.

Buyer support

Frequently asked questions about Atellica IM BR 27.29 Pre-treatment Reagent | REF 10995480

Practical answers for procurement teams reviewing this product page.

Include the exact product family, brand preference, REF/UPN code when available, required quantity, destination country, expected delivery timing and documentation expectations.

Yes. If alternatives are acceptable, mention equivalent brands, compatible models, size ranges and any non-negotiable requirements.

Related products are connected through structured catalog data such as brand, category, product family and country assignment.

No. This page supports sourcing and RFQ organization. Buyers must verify regulatory status, clinical suitability and procurement compliance independently.

Specific codes reduce ambiguity and help supplier teams identify product availability, packaging details and documentation faster.

Yes. The workflow is designed for hospitals, clinics, distributors, wholesalers, importers and procurement departments.

Yes. Products can be connected to multiple countries in the admin panel, and buyers can specify destination details in the RFQ form.

The request is stored with contact and procurement details so the sourcing conversation can be reviewed and followed up clearly.

Your request has been captured successfully.